Anadys
About:
Anadys Pharmaceuticals, a biopharmaceutical company, develops medicines for the treatment of hepatitis C.
Website: http://www.anadyspharma.com
Description:
Anadys Pharmaceuticals is a biopharmaceutical company dedicated to developing medicines for the treatment of hepatitis C. The company is developing ANA598, a non-nucleoside polymerase inhibitor for the treatment of hepatitis C. Anadys has also investigated the potential of ANA773, an oral, small-molecule inducer of endogenous interferons that acts via the Toll-like receptor 7, or TLR7, pathway in hepatitis C.
Total Funding Amount:
$17.5M
Headquarters Location:
San Diego, California, United States
Founded Date:
2000-01-01
Founders:
Number of Employees:
11-50
Last Funding Date:
2009-06-04
IPO Status:
Delisted
Industries:
© 2025 bioDAO.ai